A limb saved is a beginning. The next questions are deeply human: Can this person walk to the kitchen? Get back to work? Leave the house? Live independently?
Our friends in The Lancet bring the person into focus
Our friends Jonathan Golledge, Prem Chand Gupta, and their colleagues have published a thoughtful contribution to The Lancet’s peripheral arterial disease series: “Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead,” published online September 22, 2026.
The author team brings together Jonathan Golledge, Mette Søgaard, Mikael Svensson, Prem Chand Gupta, Sigrid Nikol, Paulo Eduardo Ocke Reis, Adrian Mahlmann, and F. G. R. Fowkes. Their review examines how peripheral arterial disease (PAD) affects daily life, who bears the greatest burden, and how care needs to change.
Three connected papers: understanding PAD, treating it, and improving lives
This contribution is the third paper in The Lancet’s three-part clinical Series on peripheral arterial disease, with all three papers published online September 22, 2026. Read together, they connect recognition and diagnosis, treatment, and the long-term consequences for people and health systems.
- Understanding the disease: Understanding peripheral arterial disease in the current era, by Christian-Alexander Behrendt, Lars Norgren, Chalotte W. Nicolajsen, Janet T. Powell, Vivienne Chuter, Prem Chand Gupta, Karen Woo, and Joakim Nordanstig, examines PAD’s global importance, its drivers, and the problems of underrecognition, underdiagnosis, and undertreatment.
- Choosing and delivering treatment: Current advancements in the care of peripheral arterial disease: modern approaches to medical, endovascular, and surgical treatment, by Riikka Tulamo, Andrew Bradbury, Caitlin W. Hicks, Anders Gottsäter, Prem Chand Gupta, Ulrich Rother, Birgitta Sigvant, and Robert Hinchliffe, brings together medical treatment, exercise, and decisions about revascularization.
- Preserving independence and improving access: Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead, by Jonathan Golledge and colleagues, connects the clinical burden to daily life, inequity, and the services people need.
Andrew, Caitlin, and colleagues: matching treatment to the person
The companion treatment review deserves particular attention. Riikka Tulamo, our friends Andrew Bradbury and Caitlin Hicks, and their coauthors emphasize cardiovascular risk reduction through medical therapy and behavior change. They highlight supervised exercise for improving walking in people with intermittent claudication and caution about overuse of revascularization in that group, while recognizing that selected patients may benefit.
For people with chronic limb-threatening ischemia, the stakes and treatment decisions differ. The review discusses open and endovascular approaches in the context of anatomy, comorbidity, frailty, patient preferences, and local expertise. Prem Chand Gupta contributes to all three papers—a useful connection across the entire Series.
My reading of the Series is that recognition, treatment, and recovery belong in the same conversation. The practical task is to connect earlier recognition and appropriate therapy with the mobility, independence, and access emphasized by Jon’s team.
The burden reaches into everyday life
PAD can bring persistent pain, reduced mobility, and loss of independence. The authors also describe consequences for mental wellbeing, employment, and financial security, alongside the risks of amputation, heart attack, stroke, and death.
The supplied Figure 1 makes those connections visible. It places vascular disease beside wounds, disability, frailty, social isolation, repeated hospital care, and the need for long-term support. This is a map of possible consequences, not an inevitable sequence for every person with PAD.
For those of us working in diabetic foot care and limb preservation, that framing matters. An open artery and a healed wound are meaningful milestones. We also need to ask what life looks like after them.
Access belongs in the clinical conversation
The review highlights the disproportionate burden borne by women, First Nations Peoples, other non-White populations, people facing financial insecurity, and those living remotely. Its call for better access is central to its proposed path forward.
My practical takeaway is that a care plan should include the realities of getting care. Can someone reach the clinic, obtain treatment, and participate in rehabilitation? Those questions deserve space beside the examination and the imaging.
Build care around function and independence
The authors call for greater disease awareness and multidisciplinary care that brings medical treatment and rehabilitation together. They also identify a longer-term research question: whether screening followed by early medical management can reduce the burden of PAD.
For our limb-preservation community, I see three useful questions to bring into team discussions:
- What does this person want to be able to do again?
- What barriers could prevent them from receiving or continuing care?
- How will we follow mobility, daily function, and quality of life alongside wound healing and limb outcomes?
A useful distinction about the evidence
This article is a review and a set of recommendations. It does not report a new randomized trial demonstrating that a particular screening program or service model improves outcomes. The authors’ call to test earlier detection and treatment should retain that distinction.
This commentary draws on the three articles’ indexed abstracts, the publisher’s available treatment-review summary and section excerpts, and the authors’ Figure 1 supplied for this post. The practical questions above are my interpretation for limb-preservation teams.
Congratulations to the teams across the Series
Congratulations to Jon, Prem, Andrew, Caitlin, and the colleagues across all three papers. Thank you for putting the lived consequences of PAD, and the people too often underserved by our systems, at the center of the discussion. This is a valuable contribution for everyone working to preserve limbs, mobility, and independence.
Featured figure credit
Figure 1 from Golledge J, Søgaard M, Svensson M, Gupta PC, Nikol S, Reis PEO, Mahlmann A, Fowkes FGR. The Lancet (2026). © 2026 The Author(s), published by Elsevier Ltd. Reproduced unchanged for this educational commentary under CC BY-NC-ND 4.0.
Related reading
- Read the indexed abstract in PubMed
- Figure 1 and the full article at The Lancet
- Figure reuse license: CC BY-NC-ND 4.0
References
- Behrendt CA, Norgren L, Nicolajsen CW, Powell JT, Chuter V, Gupta PC, Woo K, Nordanstig J. Understanding peripheral arterial disease in the current era. The Lancet. Published online September 22, 2026. doi:10.1016/S0140-6736(26)00846-9.
- Tulamo R, Bradbury A, Hicks CW, Gottsäter A, Gupta PC, Rother U, Sigvant B, Hinchliffe R. Current advancements in the care of peripheral arterial disease: modern approaches to medical, endovascular, and surgical treatment. The Lancet. Published online September 22, 2026. doi:10.1016/S0140-6736(26)00845-7.
- Golledge J, Søgaard M, Svensson M, Gupta PC, Nikol S, Reis PEO, Mahlmann A, Fowkes FGR. Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead. The Lancet. Published online September 22, 2026. doi:10.1016/S0140-6736(26)00847-0.
The outcome we are working toward is a person who can keep living their life.
Leave a Reply